Excess accumulation of fat in the liver is associated with dysregulated whole-body glucose and insulin homeostasis [2], as well as dyslipidemia [3], and the recognition of the association to metabolic comorbidities has led to the proposal of a new nomenclature: metabolic dysfunction associated fatty liver disease [4]. Here, INS is linked to fatty liver disease.